Fundz

Hancock Prospecting invests US$50 million in Lumitron to support scaling of its HyperVIEW™ technology for healthcare and mining applications.

PRIVATEJun 25, 2026

Amount Raised

$50 Million

Round Type

Funding Round

AustraliaBiotechnologyHealth CareMedical Device

Investors

Hancock Prospecting

Description

Hancock Prospecting has provided an initial US$50 million investment into Lumitron, with a right to increase to US$100 million during 2026. This funding will enable Lumitron to commercialize its HyperVIEW™ technology across cancer care and industrial sectors. Hancock will have two members on the technical review committee, enhancing collaboration. This partnership aims to introduce advanced cancer detection and treatment systems in Australia.

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as Lumitron that raised within 45 days of this round, from Fundz verified event records.

  • Femasys raised $30M (Post-IPO Equity) on August 7, 2026.
  • Nano-X Imaging Ltd. raised $8M (Post-IPO Equity) on August 6, 2026.
  • Body Vision Medical raised an undisclosed amount on August 6, 2026.
  • Vexev raised $6M on August 6, 2026.
  • Carvolix raised $35M (Debt Financing) on August 6, 2026.
  • Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.

Who to call at Lumitron, and when

A new round usually means Lumitron is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lumitron raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lumitron, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lumitron. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lumitron

Location

Australia

About

Lumitron Technologies has developed HyperVIEW™, a world-first platform of imaging systems and electron beam radiotherapy machines designed to deliver ultra-high-resolution X-ray imaging and VHEE beam radiotherapy. This innovative technology signifies a fundamental change in clinical radiotherapy and radiography, offering greater imaging resolution and reduced radiation doses. Lumitron aims to transform cancer detection and treatment through advanced technologies deployable in clinical environments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lumitron raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lumitron's next move

See what Strategic adds

Lumitron raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.